These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
775 related items for PubMed ID: 18294794
1. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F, MMKD Study Group. Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794 [Abstract] [Full Text] [Related]
2. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P. J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479 [Abstract] [Full Text] [Related]
3. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP, Leung KT, Tong MK, Kwan TH. Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385 [Abstract] [Full Text] [Related]
4. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Othman M, Kawar B, El Nahas AM. Nephron Clin Pract; 2009 Jan; 113(1):c16-23. PubMed ID: 19590231 [Abstract] [Full Text] [Related]
5. Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study. Boes E, Fliser D, Ritz E, König P, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Riegler P, Kronenberg F. J Am Soc Nephrol; 2006 Feb; 17(2):528-36. PubMed ID: 16382017 [Abstract] [Full Text] [Related]
6. Relationship of uric acid with progression of kidney disease. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF. Am J Kidney Dis; 2007 Aug; 50(2):239-47. PubMed ID: 17660025 [Abstract] [Full Text] [Related]
11. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Jones C, Roderick P, Harris S, Rogerson M. Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779 [Abstract] [Full Text] [Related]
12. Predictors of new-onset decline in kidney function in a general middle-european population. Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, Ponholzer A, Madersbacher S, Oberbauer R, Klauser-Braun R. Nephrol Dial Transplant; 2008 Apr; 23(4):1265-73. PubMed ID: 18039642 [Abstract] [Full Text] [Related]
14. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G. Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656 [Abstract] [Full Text] [Related]
15. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Levin A, Djurdjev O, Beaulieu M, Er L. Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347 [Abstract] [Full Text] [Related]